Inventor
AYA JAKOBOVITS
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes16%
A61NElectrotherapy3%
C07HSugars3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
12,371,663Engineered gd T-cells202512,364,714Methods for selective expansion of gamma delta t-cell populations and compositions thereof202512,221,480Methods for selective expansion of delta-3 gamma delta T-cell populations and compositions thereof202511,559,582Antibody drug conjugates (ADC) that bind to 191P4D12 proteins202311,485,785Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof202211,401,347Antibodies and molecules derived therefrom that bind to STEAP-1 proteins202211,299,708Methods for selective expansion of gd T-cell populations and compositions thereof202211,135,245Engineered gd T-cells2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2022Patents assigned to ADICET BIO INC (3)· patent assignee history
2021–2025Based in US· patent location history
2022–2023Patents assigned to AGENSYS INC (2)· patent assignee history
2023Patents assigned to SEAGEN INC (1)· patent assignee history
2025Patents assigned to ADICET THERAPEUTICS INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ADICET BIO INC | 3 | 2021–2022 |
| ADICET THERAPEUTICS INC | 3 | 2025 |
| AGENSYS INC | 2 | 2022–2023 |
| SEAGEN INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2025 |